DEVELOPING A MECHANISTIC UNDERSTANDING TO LINK ALK MUTATIONS TO PROGNOSIS AND THERAPEUTIC INHIBITOR CHOICE IN NEUROBLASTOMA PATIENTS
$571,937FY2010Department of the ArmyDOD
Trustees Of The University Of Pennsylvania, The
Trustees Of The University Of Pennsylvania, The